When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.” ...

AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customise their workflows and explore a wider array of ...

The launch was supported by collaborations with institutions such as the Hartwig Medical Foundation and Broad Clinical Labs.

Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist ...

Roche debuts Axelios, a gene sequencer targeting academic and research facilities, to compete with Illumina's dominance in ...

Next-generation sequencing (NGS) technologies have revolutionised phylogenetic analysis by enabling the acquisition of genome-scale data. Phylogenetic inference reconstructs evolutionary relationships ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...

Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing ...

We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

In just a few decades, DNA sequencing technologies evolved from slow, manual processes to rapid, automated ones, making ...

In a way, sequencing DNA is very simple: There's a molecule, you look at it, and you write down what you find. You'd think it would be easy—and, for any one letter in the sequence, it is. The problem ...